-+ 0.00%
-+ 0.00%
-+ 0.00%

Astellas Pharma (4503) 1Q operating profit increased by 94.9% (184.5 billion yen for April-June consolidated IFRS), forecast for March 2027 (395 billion yen)

NIKKEI QUICK·08/05/2026 06:36:25

Please log in to view news